what are the side effects of tirzepatide caused roughly half as many patients to stop treatment because gastrointestinal as semaglutide. In first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Side Effects of Weight Loss

A second direction of the interrelationship between psoriasis and obesity indicates that patients with psoriasis have elevated levels of inflammatory cytokines, particularly TNF-, which can lead to metabolic abnormalities, including insulin resistance, and may consequently lead to the development of obesity (211)

DSIP Peptide Dosage, Injection Protocols, Administration, and Research Limitations Short Answer: There is no standardized or medically approved DSIP dosage protocol, and existing research dosing does not translate into safe consumer use

The lyophilized tirzepatide complete guide covers this in detail

There's absolutely no evidence of this happening at the moment